Bioengineering professor and The Grainger College of Engineering's Dean, Rashid Bashir, led a team of researchers in a ...
University of Illinois at Urbana-Champaign researchers have developed a CRISPR-based diagnostic tool capable of detecting ...
2d
News-Medical.Net on MSNCRISPR technologies paving the way for advances in regenerative medicineA recent review published in the journal Engineering delves into the significant advancements and potential of CRISPR ...
2don MSNOpinion
India has the chance to lead in CRISPR technology by driving ethical gene editing innovations in healthcare, agriculture, and ...
The Cambridge-based company touted the data as evidence of the first successful use of CRISPR gene editing to fix a ...
2d
Discover Magazine on MSNCRISPR Eliminates Targeted Tumors by 50 PercentLearn more about how a research team has successfully used CRISPR gene editing in the fight against cancer.
Researchers at Duke University and North Carolina State University have discovered a handful of new CRISPR-Cas systems that ...
CRISPR Therapeutics' stock faces challenges with slow Casgevy adoption and competition. See how CRSP stock remains a cautious ...
CRISPR Therapeutics AG (NASDAQ:CRSP – Get Free Report) fell 2.9% on Thursday after an insider sold shares in the company. The company traded as low as $42.78 and last traded at $42.22. 282,558 shares ...
4d
GlobalData on MSNElevateBio taps Amazon’s genAI tools to design CRISPR therapeuticsAWS’s framework will speed up the analysis of ElevateBio’s large protein datasets, hinting at promising drug candidates.
Shares of CRISPR Therapeutics AG (NASDAQ:CRSP – Get Free Report) have been assigned a consensus recommendation of “Hold” from ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results